Chicago Equity Partners LLC Raises Stake in UnitedHealth Group Incorporated (UNH)

Chicago Equity Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,855 shares of the healthcare conglomerate’s stock after buying an additional 1,620 shares during the period. Chicago Equity Partners LLC’s holdings in UnitedHealth Group were worth $7,120,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Hanson McClain Inc. increased its position in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares during the period. Kanaly Trust Co increased its position in UnitedHealth Group by 0.6% in the second quarter. Kanaly Trust Co now owns 1,772 shares of the healthcare conglomerate’s stock valued at $250,000 after buying an additional 11 shares during the period. Burke & Herbert Bank & Trust Co. increased its position in UnitedHealth Group by 0.4% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 2,877 shares of the healthcare conglomerate’s stock valued at $403,000 after buying an additional 12 shares during the period. Integrated Wealth Management increased its position in UnitedHealth Group by 2.8% in the third quarter. Integrated Wealth Management now owns 1,135 shares of the healthcare conglomerate’s stock valued at $159,000 after buying an additional 31 shares during the period. Finally, GHP Investment Advisors Inc. increased its position in UnitedHealth Group by 0.5% in the third quarter. GHP Investment Advisors Inc. now owns 7,912 shares of the healthcare conglomerate’s stock valued at $1,108,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 84.80% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.25% during midday trading on Wednesday, reaching $161.98. 1,270,767 shares of the company’s stock traded hands. The stock has a 50 day moving average of $159.76 and a 200-day moving average of $145.28. UnitedHealth Group Incorporated has a 52-week low of $107.51 and a 52-week high of $164.00. The stock has a market cap of $154.18 billion, a price-to-earnings ratio of 23.93 and a beta of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.09. The company earned $46.30 billion during the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The business’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period last year, the business earned $1.77 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post $8.02 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Friday, December 2nd were paid a dividend of $0.625 per share. The ex-dividend date was Wednesday, November 30th. This represents a $2.50 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 36.93%.

ILLEGAL ACTIVITY WARNING: “Chicago Equity Partners LLC Raises Stake in UnitedHealth Group Incorporated (UNH)” was published by BBNS and is the propert of of BBNS. If you are accessing this story on another publication, it was stolen and reposted in violation of US & international copyright & trademark laws. The original version of this story can be accessed at https://baseballnewssource.com/markets/chicago-equity-partners-llc-raises-stake-in-unitedhealth-group-incorporated-unh/344817.html.

Several research firms have recently weighed in on UNH. Cowen and Company set a $175.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Wednesday, November 30th. Jefferies Group reissued a “buy” rating and issued a $2.30 target price on shares of UnitedHealth Group in a research report on Tuesday. Credit Suisse Group reissued an “outperform” rating and issued a $160.00 target price (up from $155.00) on shares of UnitedHealth Group in a research report on Friday, October 21st. Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $168.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. Finally, RBC Capital Markets lifted their target price on shares of UnitedHealth Group from $168.00 to $175.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. Twenty-two equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $165.62.

In related news, Director Gail R. Wilensky sold 5,460 shares of the firm’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $150.55, for a total value of $822,003.00. Following the completion of the transaction, the director now directly owns 60,052 shares of the company’s stock, valued at $9,040,828.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kenneth Irwin Shine sold 325 shares of the firm’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $144.99, for a total transaction of $47,121.75. Following the completion of the transaction, the director now directly owns 28,613 shares of the company’s stock, valued at $4,148,598.87. The disclosure for this sale can be found here. Insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.

 

Latest News

Toronto and Jose Bautista Agree to One-Year Deal
Toronto and Jose Bautista Agree to One-Year Deal
Orioles Talking Contract with Slugger Jose Bautista
Orioles Talking Contract with Slugger Jose Bautista
Criticism During World Series Humorous to Joe Maddon
Criticism During World Series Humorous to Joe Maddon
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Manny Ramirez Returning to Play Baseball in Japan
Manny Ramirez Returning to Play Baseball in Japan
Rajai Davis Anxious to Start Second Stint With Oakland
Rajai Davis Anxious to Start Second Stint With Oakland


Leave a Reply

 
© 2006-2017 BBNS.